作者的详细信息
Тумян, Гаяне Сергеевна
期 | 栏目 | 标题 | 文件 |
卷 22, 编号 1 (2020) | CLINICAL ONCOLOGY | ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution |
(Rus) |
卷 22, 编号 2 (2020) | Guidelines | Hodgkin's lymphoma |
(Rus) |
卷 22, 编号 2 (2020) | Guidelines | Follicular lymphoma |
(Rus) |
卷 22, 编号 2 (2020) | Conference Proceedings | Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic |
(Rus) |
卷 23, 编号 1 (2021) | CLINICAL ONCOLOGY | Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas |
(Rus) |